BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

800 related articles for article (PubMed ID: 33266292)

  • 21. [Personalized medicine in psychiatry: nightmare of the industry?].
    Lazary J; Elemery M; Csala I; Faludi G
    Neuropsychopharmacol Hung; 2016 Sep; 18(3):137-142. PubMed ID: 27824309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
    Bousman C; Maruf AA; Müller DJ
    Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamic and pharmacokinetic interactions of psychotropic drugs with antiepileptic drugs.
    Kanner AM; Gidal BE
    Int Rev Neurobiol; 2008; 83():397-416. PubMed ID: 18929094
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Systems Biology Approach for Personalized Medicine in Refractory Epilepsy.
    Naimo GD; Guarnaccia M; Sprovieri T; Ungaro C; Conforti FL; Andò S; Cavallaro S
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31366017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacogenomics and epilepsy: the road ahead.
    Cavalleri GL; McCormack M; Alhusaini S; Chaila E; Delanty N
    Pharmacogenomics; 2011 Oct; 12(10):1429-47. PubMed ID: 22008048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precision psychiatry in clinical practice.
    Zanardi R; Prestifilippo D; Fabbri C; Colombo C; Maron E; Serretti A
    Int J Psychiatry Clin Pract; 2021 Mar; 25(1):19-27. PubMed ID: 32852246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Precision Medicine in Child Psychiatry: What Can We Expect and When?
    Posner J
    J Am Acad Child Adolesc Psychiatry; 2018 Nov; 57(11):813-817. PubMed ID: 30392618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Personalized Medicine and Mood Disorders.
    Alhajji L; Nemeroff CB
    Psychiatr Clin North Am; 2015 Sep; 38(3):395-403. PubMed ID: 26300030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Toward a Global Roadmap for Precision Medicine in Psychiatry: Challenges and Opportunities.
    Dalvie S; Koen N; McGregor N; O'Connell K; Warnich L; Ramesar R; Nievergelt CM; Stein DJ
    OMICS; 2016 Oct; 20(10):557-564. PubMed ID: 27636104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mental disorders of known aetiology and precision medicine in psychiatry: a promising but neglected alliance.
    Fraguas D; Díaz-Caneja CM; State MW; O'Donovan MC; Gur RE; Arango C
    Psychol Med; 2017 Jan; 47(2):193-197. PubMed ID: 27334937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Personalized pharmacotherapy in psychiatry.
    Filaković P; Petek A
    Psychiatr Danub; 2009 Sep; 21(3):341-6. PubMed ID: 19794353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy for neurobehavioral disorders in epilepsy.
    Devinsky O
    Epilepsia; 2004; 45 Suppl 2():34-40. PubMed ID: 15186343
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacogenomics in psychiatry: clinical issues to be considered.
    Licinio J; Wong ML
    Mol Psychiatry; 2005 Jul; 10(7):615. PubMed ID: 15976808
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of genetics and genomics in clinical psychiatry.
    Hoehe MR; Morris-Rosendahl DJ
    Dialogues Clin Neurosci; 2018 Sep; 20(3):169-177. PubMed ID: 30581286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of treatment outcomes in psychiatry--where do we stand ?
    McMahon FJ
    Dialogues Clin Neurosci; 2014 Dec; 16(4):455-64. PubMed ID: 25733951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Daniel K. Inouye College of Pharmacy Scripts: Precision Medicine Through the Use of Pharmacogenomics: Current Status and Barriers to Implementation.
    Ciarleglio AE; Ma C
    Hawaii J Med Public Health; 2017 Sep; 76(9):265-269. PubMed ID: 28900583
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of antiepileptic drugs in epileptology with respect to psychiatry.
    Wolf P
    Neuropsychobiology; 1993; 27(3):127-31. PubMed ID: 8232826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiepileptic drugs in the treatment of psychiatric disorders.
    Kaufman KR
    Epilepsy Behav; 2011 May; 21(1):1-11. PubMed ID: 21498130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miRNAs as potential diagnostic biomarkers and pharmacogenomic indicators in psychiatric disorders.
    Tsermpini EE; Kalogirou CI; Kyriakopoulos GC; Patrinos GP; Stathopoulos C
    Pharmacogenomics J; 2022 Jul; 22(4):211-222. PubMed ID: 35725816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Personalized medicine in psychiatry.
    Wium-Andersen IK; Vinberg M; Kessing LV; McIntyre RS
    Nord J Psychiatry; 2017 Jan; 71(1):12-19. PubMed ID: 27564242
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.